131 related articles for article (PubMed ID: 9231061)
1. In vivo and in vitro effects of somatostatin and insulin on glucagon release in a human glucagonoma.
Waeber G; Gomez F; Chaubert P; Temler E; Chapuis G; Boulat O; Nicod P; Haefliger JA
Clin Endocrinol (Oxf); 1997 May; 46(5):637-42. PubMed ID: 9231061
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholine regulates glucagon secretion from human glucagonoma cells.
Funakoshi A; Yasunami Y; Ryu S; Shinozaki H; Jimi A; Ikeda S
J Gastroenterol; 1994 Dec; 29(6):797-9. PubMed ID: 7874280
[TBL] [Abstract][Full Text] [Related]
3. Calcium reverses octreotide inhibition of insulin and glucagon levels in patients with insulinoma and glucagonoma.
Thompson CS; O'Dorisio TM; Woltering EA
Digestion; 1996; 57 Suppl 1():62-8. PubMed ID: 8813473
[TBL] [Abstract][Full Text] [Related]
4. Multiple hormone secretion by a human pancreatic glucagonoma in culture.
White A; Tan K; Gray C; Roberts I; Ratcliffe JG
Regul Pept; 1985 Aug; 11(4):335-45. PubMed ID: 2864720
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
[TBL] [Abstract][Full Text] [Related]
6. Plasma glucagon levels suppressed by a glucose load in a man with incidental pancreatic glucagonoma.
Mai VQ; Jones RC; Dickert JM; Clyde PW; Shakir KM
Endocr Pract; 2007; 13(7):780-4. PubMed ID: 18194937
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin analogue and tissue cultures in the study of a human malignant glucagonoma.
Ahlman H; Ahlund L; Dahlström A; Grimelius L; Theodorsson E
J Surg Oncol; 1990 Jul; 44(3):191-9. PubMed ID: 2164620
[TBL] [Abstract][Full Text] [Related]
8. Insulinoma associated with a case of multiple endocrine neoplasia type I: Functional somatostatin receptors and abnormal glucose-induced insulin secretion.
Waeber G; Gomez F; Bishof-Delaloye A; Chaubert P; Francke ML; Haefliger JA; Scherrer U; Centeno G; Temler E; Nicod P
Horm Res; 1997; 48(2):76-82. PubMed ID: 9251924
[TBL] [Abstract][Full Text] [Related]
9. Amino acid, glucose, and lipid kinetics after palliative resection in a patient with glucagonoma syndrome.
Bernstein M; Jahoor F; Townsend CM; Klein S
Metabolism; 2001 Jun; 50(6):720-2. PubMed ID: 11398151
[TBL] [Abstract][Full Text] [Related]
10. [Necrolytic migratory erythema revealing glucagonoma without diabetes].
Marty C; Bennet A; Bayle P; Danjoux M; Lalande T; Marguery MC; Bazex J
Ann Med Interne (Paris); 2003 Dec; 154(8):552-6. PubMed ID: 15037834
[TBL] [Abstract][Full Text] [Related]
11. [Glucagonoma syndrome in a multihormonal pancreatic tumor].
Keller U; Fankhauser S; Schumacher A; Trimble ER; Heitz PU
Schweiz Med Wochenschr; 1982 Feb; 112(9):297-304. PubMed ID: 6281878
[TBL] [Abstract][Full Text] [Related]
12. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
Torre L; Vazquez JA; Blázquez E
Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
[TBL] [Abstract][Full Text] [Related]
13. The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth.
Jockenhövel F; Lederbogen S; Olbricht T; Schmidt-Gayk H; Krenning EP; Lamberts SW; Reinwein D
Clin Investig; 1994 Jan; 72(2):127-33. PubMed ID: 8186658
[TBL] [Abstract][Full Text] [Related]
14. Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides.
Rindi G; Efrat S; Ghatei MA; Bloom SR; Solcia E; Polak JM
Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):115-29. PubMed ID: 1678563
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical staining for islet amyloid polypeptide in pancreatic endocrine tumors.
Tomita T
Islets; 2011; 3(6):344-51. PubMed ID: 21983096
[TBL] [Abstract][Full Text] [Related]
16. Glucagonoma syndrome.
Bloom SR; Polak JM
Am J Med; 1987 May; 82(5B):25-36. PubMed ID: 2884877
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic endocrine carcinoma with multiple hormone production in a raccoon (Procyon lotor).
Yoshikawa K; Matsuura S; Tsuchiya T; Kadota K
J Comp Pathol; 1999 Apr; 120(3):301-6. PubMed ID: 10213674
[TBL] [Abstract][Full Text] [Related]
18. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
Drucker DJ; Asa SL; Silverberg J; Brubaker PL
Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
[TBL] [Abstract][Full Text] [Related]
19. Metabolic studies and glucagon gel filtration pattern before and after surgery in a case of glucagonoma syndrome.
von Schenck H; Thorell JI; Berg J; Bojs G; Dymling JF; Hallengren B; Ljungberg O; Tibblin S
Acta Med Scand; 1979; 205(3):155-62. PubMed ID: 218426
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo studies on glucagonoma tissue.
Berger M; Teuscher A; Halban P; Trimble E; Studer PP; Wollheim CB; Zimmermann-Telschow H; Muller WA
Horm Metab Res; 1980 Apr; 12(4):144-50. PubMed ID: 6104627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
